These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 9535166

  • 1. Drug targeting via retrometabolic approaches.
    Bodor N, Buchwald P.
    Pharmacol Ther; 1997; 76(1-3):1-27. PubMed ID: 9535166
    [Abstract] [Full Text] [Related]

  • 2. Retrometabolic approaches for drug design and targeting.
    Bodor N.
    Pharmazie; 1997 Jul; 52(7):491-4. PubMed ID: 9266587
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recent advances in retrometabolic drug design and targeting approaches.
    Bodor N.
    Pharmazie; 2000 Mar; 55(3):163-6. PubMed ID: 10756533
    [Abstract] [Full Text] [Related]

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 6. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK, Jain SK.
    J Pharm Pharm Sci; 2003 Dec; 6(1):33-66. PubMed ID: 12753729
    [Abstract] [Full Text] [Related]

  • 7. Drug targeting by retrometabolic design: soft drugs and chemical delivery systems.
    Bodor N, Buchwald P.
    J Recept Signal Transduct Res; 2001 Dec; 21(2-3):287-310. PubMed ID: 11757686
    [No Abstract] [Full Text] [Related]

  • 8. Mathematical modeling of drug delivery.
    Siepmann J, Siepmann F.
    Int J Pharm; 2008 Dec 08; 364(2):328-43. PubMed ID: 18822362
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recent advances in retrometabolic drug design (RMDD) and development.
    Bodor N, Buchwald P.
    Pharmazie; 2010 Jun 08; 65(6):395-403. PubMed ID: 20614685
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR.
    Yao Xue Xue Bao; 2008 Mar 08; 43(3):227-33. PubMed ID: 18630256
    [Abstract] [Full Text] [Related]

  • 18. Colonic drug delivery: an updated review.
    Shareef MA, Khar RK, Ahuja A, Ahmad FJ, Raghava S.
    AAPS PharmSci; 2003 Mar 08; 5(2):E17. PubMed ID: 12866944
    [Abstract] [Full Text] [Related]

  • 19. [Drug delivery systems].
    Sezaki H.
    Gan To Kagaku Ryoho; 1985 Nov 08; 12(11):2077-82. PubMed ID: 3904633
    [Abstract] [Full Text] [Related]

  • 20. Designing transient binding drugs: a new concept for drug discovery.
    Ohlson S.
    Drug Discov Today; 2008 May 08; 13(9-10):433-9. PubMed ID: 18468561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.